BMC Endocrine Disorders

OCT 23, 2026 · JOURNAL ARTICLE

Metabolic syndrome-like phenotype, BMI-based metabolic burden, and size-threshold thyroid nodules: a cross-sectional study of 50,023 health-examination attendees

BMC Endocrine Disorders

Metabolic syndrome (MetS) has been linked to thyroid nodules, but most evidence relies on any-size detection dominated by clinically trivial lesions and adjusts for few confounders

OCT 15, 2026 · JOURNAL ARTICLE

Metabolic correlates of biochemically low total testosterone among men participating in a national WHO STEPS survey in Kazakhstan

BMC Endocrine Disorders

Abstract Introduction Low total testosterone in men is associated with adverse metabolic health, but population-based data from Central Asia remain limited. Aim To estimate the pre

OCT 14, 2026 · JOURNAL ARTICLE

Association of the uric acid-to-HDL cholesterol ratio with a study-defined dysmetabolic phenotype in adults with obesity: a cross-sectional study

BMC Endocrine Disorders

The uric acid-to-HDL cholesterol ratio (UHR) has been proposed as a composite marker of metabolic dysregulation. This study aimed to evaluate the association between UHR and a stud

OCT 13, 2026 · JOURNAL ARTICLE

Acanthosis nigricans as a cutaneous marker of compensatory hyperinsulinemia with preserved glycemia: a cross-sectional study

BMC Endocrine Disorders

Abstract Purpose Acanthosis nigricans is associated with insulin resistance and hyperinsulinemia; however, its distribution across predefined metabolic stages remains poorly charac

OCT 13, 2026 · JOURNAL ARTICLE

Development and internal validation of an interpretable model for MASLD identification using metabolic and body composition indicators in middle-aged and older adults

BMC Endocrine Disorders

Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to metabolic dysfunction, insulin resistance, dyslipidemia, obesity, and altered body composition

OCT 9, 2026 · JOURNAL ARTICLE

The effect of optimal glycemic control and anthropometric control on the FIB-4 index in patients with type 2 diabetes mellitus and metabolic-associated fatty liver disease

BMC Endocrine Disorders

Metabolic dysfunction–associated steatotic liver disease (MASLD) is highly prevalent in type 2 diabetes mellitus (T2DM), in which hyperglycemia and obesity act synergistically to d

OCT 6, 2026 · JOURNAL ARTICLE

Diet quality assessed by the Lifelines Diet Score and cardiometabolic risk indices in overweight and obese Iranian adults: implications for cardiometabolic physiology

BMC Endocrine Disorders

Iranian studies have examined the Lifelines Diet Score (LLDS) in relation to selected anthropometric and metabolic phenotypes, but its association with the Atherogenic Index of Pla

OCT 4, 2026 · JOURNAL ARTICLE

Metabolic and reproductive outcomes in lean versus overweight/obese phenotypes of polyendocrine metabolic ovarian syndrome: a retrospective cohort study with long-term follow-up

BMC Endocrine Disorders

Polyendocrine metabolic ovarian syndrome (PMOS; formerly polycystic ovary syndrome [PCOS]) is the most common endocrinopathy in reproductive-age women. Whether lean (BMI < 25 kg/m²